Intrathymic NKT cell development is blocked by the presence of α-galactosylceramide

European Journal of Immunology

Volumn 33, Issue 7, 2003, Pages 1816-1823

  Pellicci, Daniel G ^a   Uldrich, Adam P ^a   Kyparissoudis, Konstantinos ^a   Crowe, Nadine Y ^a   Brooks, Andrew G ^b   Hammond, Kirsten J L ^c   Sidobre, Stephané ^c   Kronenberg, Mitchell ^c   Smyth, Mark J ^d   Godfrey, Dale ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

NKT cell; T lymphocyte; Thymus; Tolerance

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GALACTOSYLCERAMIDE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; ALPHA GALACTOSIDASE;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL MATURATION; CELL SELECTION; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DEPLETION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMUS; ANIMAL; CELL DIFFERENTIATION; DRUG EFFECT; METABOLISM;

ALPHA-GALACTOSIDASE; ANIMALS; CELL DIFFERENTIATION; KILLER CELLS, NATURAL; MICE; THYMUS GLAND;

EID: 0042970538     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323894     Document Type: Article

References (32)

1. Bendelac, A., Rivera, M. N., Park, S. H. and Roark, J. H., Mouse CD1-specific NK1 T cells - development, specificity, and function. Annu. Rev. Immunol. 1997. 15: 535-562.
2. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G., NKT cells: facts, functions and fallacies. Immunol. Today 2000. 21: 573-583.
3. Kronenberg, M. and Gapin, L., The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002. 2: 557-568.
4. Crowe, N. Y., Smyth, M. J. and Godfrey, D. I., A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 2002. 196: 119-127.
5. Smyth, M. J., Crowe, N. Y., Takeda, K., Yagita, H. and Godfrey, D. I., NKT cells - conductors of tumor immunity? Curr. Opin. Immunol. 2002. 14: 165-171.
6. Hammond, K. J. and Godfrey, D. I., NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 2002. 59: 353-363.
7. Hong, S. M., Scherer, D. C., Singh, N., Mendiratta, S. K., Serizawa, I., Koezuka, Y. and Van Kaer, L., Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol. Rev. 1999. 169: 31-44.
8. Sidobre, S., Naidenko, O. V., Sim, B. C., Gascoigne, N. R., Garcia, K. C. and Kronenberg, M., The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 2002. 169: 1340-1348.
9. Benlagha, K., Kyin, T., Beavis, A., Teyton, L. and Bendelac, A., A thymic precursor to the NK T cell lineage. Science 2002. 296: 553-555.
10. Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J. and MacDonald, H. R., Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells. J. Immunol. 1999. 162: 6410-6419.
11. Gapin, L., Matsuda, J. L., Surlh, C. D. and Kronenberg, M., NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2001. 2: 971-978.
12. + T cells. Int. Immunol. 1998. 10: 1491-1499.
13. Hammond, K. J. L., Pelikan, S. B., Crowe, N. Y., Randle-Barrett, E., Nakayama, T., Taniguchi, M., Smyth, M. J., van Driel, I. R., Scollay, R., Baxter, A. G. and Godfrey, D. I., NKT cells are phenotypically and functionally diverse. Eur. J. Immunol. 1999. 29: 3768-3781.
14. (+) CD1d-dependent precursor stage. J. Exp. Med. 2002. 195: 835-844.
15. + cells. J. Immunol. 2000. 164: 2412-2418.
16. + natural killer-T cell development. Eur. J. Immunol. 1999. 29: 3313-3318.
17. MacDonald, H. R., Development and selection of NKT cells. Curr. Opin. Immunol. 2002, 14: 250-254.
18. Matsuda, J. L., Gapin, L., Fazilleau, N., Warren, K., Naidenko, O. V. and Kronenberg, M., Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proc. Natl. Acad. Sci. USA 2001. 98: 12636-12641.
19. + NK T cells. J. Immunol. 2001. 166: 1755-1762.
20. Park, S. H., Roark, J. H. and Bendelac, A., Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 1998. 160: 3128-3134.
21. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
22. + T cells lose NK1.1 expression upon in vitro activation. J. Immunol. 1997. 158: 5112-5119.
23. Osman, Y., Kawamura, T., Naito, T., Takeda, K., Van Kaer, L., Okumura, K. and Abo, T., Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur. J. Immunol. 2000. 30: 1919-1928.
24. Chiu, Y. H., Jayawardena, J., Weiss, A., Lee, D., Park, S. H., Dautry-Varsat, A. and Bendelac, A., Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 1999. 189: 103-110.
25. (+) T cell selection and maturation by cathepsin S. Immunity 2001. 15: 909-919.
26. Honey, K., Benlagha, K., Beers, C., Forbush, K., Teyton, L., Kleijmeer, M. J., Rudensky, A. Y. and Bendelac, A., Thymocyte expression of cathepsin L is essential for NKT cell development. Nat. Immunol. 2002. 3: 1069-1074.
27. (+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 2002. 99: 1259-1266.
28. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. and Bendelac, A., In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 2000. 191: 1895-1903.
29. MacDonald, H. R., CD1d-glycolipid tetramers: a new tool to monitor natural killer T cells in health and disease. J. Exp. Med. 2000. 192: 15-20.
30. Leite-de-Moraes, M. C., Herbelin, A., Gouarin, C., Koezuka, Y., Schneider, E. and Dy, M., Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J. Immunol. 2000. 165: 4367-4371.
31. Hayakawa, Y., Takeda, K., Yagita, H., Kakuta, S., Iwakura, Y., Van Kaer, L., Saiki, I. and Okumura, K., Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide. Eur. J. Immunol. 2001. 31: 1720-1727.
32. Godfrey, D. I., Kennedy, J., Gately, M. K., Hakimi, J., Hubbard, B. R. and Zlotnik, A., IL-12 influences intrathymic T cell development. J. Immunol. 1994. 152: 2729-2735.